Carnegie Mellon University
(UPDATE: Monday, January 4, 2022)

Due to the current COVID surge, we’ve decided to move our In-Person Biotech Job Fair on Wednesday, January 19th to completely virtual. See below for more information.

Registration for the Wednesday, January 19th Job Fair is currently in the works. When available, participants are allowed to sign up for a 15-minute information session on Zoom with any of the companies. There is a limit of 3 students per 15-min session. It is first-come, first-serve.

**To receive an update for open registration, please sign up through this Google form or check the registration link here:

IMPORTANT: After you register on Eventbrite, you will receive an email confirmation with all details of your order. Please read the entire email and in the section titled "REGISTRATION INFORMATION", you will find the time slot that you signed up for. In the bottom section titled "ADDITIONAL INFORMATION", you will find the ZOOM link that you may paste into your own calendar.

Please be courteous and be on time for your appointment with all companies. If you have any questions or concerns, please contact (Ally Ricarte, 412-268-4206, GHC 7725). Thank you!

 January 19 & 20, 2022

You're invited to participate in the inaugural BioTech Job Fair hosted by the Carnegie Mellon University Computational Biology Department!  Meet industry representatives and alum scientists working in biotech and pharma!  Register before Monday, January 3, 2022 at 5pm.

IMPORTANT: The Virtual Job Fair on Thu Jan 20 will only include companies who are unable to join us due to the travel restrictions.  We encourage all participants to register for both the in-person and virtual job fairs!

    • Twist
      • Company Representatives: Yashi Manjuinath [MSAS Alum]. Karl Moore, Monica Jones
    • Amgen
      • An American multinational biopharmaceutical company
      • Company Representative: Christopher Langmead [CMU Faculty]
    • Bioconductor
      • Bioconductor develops open source software for the analysis of high-throughput genomic data.
      • Company Representative: Nitesh Turaga [MSCB Alum]
      • Website
    • BlueSphere Bio
      • Company Representatives: Alexander Muralles, Brandon Blobner
    • DNAnexus
      • Company Representative: Ben Busby
    • Helomics
      • Company Representatives: Bob Montgomery [MSCB Alum]
    • Illumina
      • Company Representatives: RIshi Verma [MSCB Alum], Anindita Dutta [CPCB Alum]
    • Ocean Genomics, Inc.
      • Transcriptome analysis application development and consulting services.
      • Company Representatives: Maya Bishop, Patrick Ropp
      • Website
    • Roivant Discovery
      • Company Representatives: Matt Baumgartner [CPCB Alum]
    • Second Genome
      • Company Representative: Brendan Wee [MSCB Alum]
    • Tempus
      • tempus-logo.png
      • Company Representatives: Yinjie Gao [MSCB Alum], Michelle Stein
    • Personalis
      • Personalis, Inc. is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies.
        Our patented ACE (Accuracy and Content Enhanced) Technology forms the foundation of all Personalis products. ACE Technology improves every individual step in the next-generation sequencing (NGS) process, from nucleic acid extraction, to sequencing assays, to data analytics. This makes it possible for us to achieve augmented coverage of difficult-to-sequence genomic regions that are missed with the use of conventional sequencing techniques.

        Using this comprehensive approach, we provide genomic data of the highest quality and accuracy to help biopharma drive their immuno-oncology clinical and biomarker discovery programs, thus enabling the rational design and development of effective cancer immunotherapies.
      • Company Representatives: Saina Mahera [MSCB Alum], Satsuki Shumate, Chris Nelson, Shital Savarkar, Teja Kolachina, Arun(deep) Singh
      • Website
      • Broad Institute
        • Based in Cambridge, Massachusetts, the Broad Institute was founded in 2004 to fulfill the promise of genomic medicine—three years after completion of the Human Genome Project, which Broad scientists helped create and lead. Our origins are rooted in genomics, and as biomedical research and knowledge have expanded since 2004, so have we. Our researchers are deeply collaborative, nimbly launching innovative, high-risk projects at every scale, inventing new technologies, building and implementing computational tools, developing new therapeutics to advance into the clinic, mentoring and training the next generation of scientists, and sharing our data and tools openly to enable breakthroughs anywhere.
        • Company Representatives: Julianna Fernandez, Simone Zhang [BSCB Alum]
        • Website
    • Calico Labs, South SF
      • calico-logotype.png 
      • Calico is a Bay Area research and development company whose mission is to harness advanced technologies to increase our understanding of the biology that controls lifespan. We use that knowledge to devise interventions that enable people to lead longer and healthier lives. We’re working in mostly uncharted areas rooted in biology and advanced technology. Executing on this mission will require an unprecedented level of interdisciplinary effort and a long-term focus for which funding is already in place. Calico employees are scientists, engineers, explorers and inventors, comfortable with the knowledge that often incremental steps lead to a giant leap.
      • Company Representatives: Jake Foley, Marian Wong

    • D. E. Shaw Research
      • Company Representatives: Jane Chen, Aashima Jhingon, Lukas Bane, Zelimir Galjanic
    • Freenome
      • We’re connecting people with next-generation blood tests for early cancer detection, powered by our multiomics+AI platform.
      • Company Representatives: RIchard Bourgon, Jesse Eaton [MSCB Alum], Rui Yang, Carlo Artieri, Ofer Shapira, Joyce Liu, Alvaro Gonzalez
      • Website
    • Guardant Health
      • Company Representative: Hao Wang [CPCB Alum]
    • La Jolla Labs
      • Company Representative: Jeff Milton [MSCB Alum]
    • Roche
      • Roche Diagnostics is a division of Roche. We develop and integrate diagnostic solutions that address the challenges of today and anticipate the needs of tomorrow. In more than 100 countries, we offer the industry’s most comprehensive in vitro diagnostics solutions, covering molecular diagnostics, clinical chemistry and immunoassays, tissue diagnostics, point of care testing, patient self-testing, next-generation sequencing, and laboratory automation and IT, and decision support solutions.
      • Company Representative: Myles Mao 
      • Website